USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
Objective: To evaluate the impact of rituximab (RTM) therapy on the clinical, morphological, and immunological parameters of lupus nephritis (LN) activity. Subjects and methods. The study included 19 patients with types III and IV LN (WHO classification) with its 6-133-month history. Their mean age...
Main Authors: | Anna Vasilyevna Torgashina, S K Solovyev, E N Aleksandrova, S G Radenska-Lopovok, E L Nasonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2010-08-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/1075 |
Similar Items
-
Clinical And Morphological Improvement Of Lupus Nephritis Treated With Rituximab
by: Tsanyan Maria E., et al.
Published: (2014-12-01) -
Lupus Nephritis, the therapy and the role of Rituximab in resistant cases
by: Hussein A. Nasir, et al.
Published: (2014-01-01) -
Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019-03-01) -
Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab
by: M É Tsanian, et al.
Published: (2013-05-01) -
CYTOKINE PROFILE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Maria Eduardovna Tsanyan, et al.
Published: (2013-12-01)